-
1
-
-
0028064764
-
A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
-
Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392
-
(1994)
Blood.
, vol.84
, pp. 1361-1392
-
-
Harris, N.L.1
Jaffe, E.S.2
Stein, H.3
-
2
-
-
1842413105
-
A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
-
The Non-Hodgkin's Lymphoma Classification Project
-
The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
-
(1997)
Blood.
, vol.89
, pp. 3909-3918
-
-
-
3
-
-
0028790440
-
Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
-
Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995;333:1540-1545
-
(1995)
N Engl J Med.
, vol.333
, pp. 1540-1545
-
-
Philip, T.1
Guglielmi, C.2
Hagenbeek, A.3
-
4
-
-
0027444652
-
A predictive model for aggressive non-Hodgkin's lymphoma
-
The International Non-Hodgkin's Lymphoma Prognostic Factors Project
-
The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
-
(1993)
N Engl J Med.
, vol.329
, pp. 987-994
-
-
-
5
-
-
0030031130
-
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma
-
Pettengell R, Radford JA, Morgenstern GR, et al. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol. 1996;14:586-592.
-
(1996)
J Clin Oncol.
, vol.14
, pp. 586-592
-
-
Pettengell, R.1
Radford, J.A.2
Morgenstern, G.R.3
-
6
-
-
0028012062
-
Prognostic factors in aggressive non-Hodgkin's lym-phoma: Who has "high-risk" disease?
-
Shipp MA. Prognostic factors in aggressive non-Hodgkin's lym-phoma: who has "high-risk" disease? Blood. 1994;83:1165-1173.
-
(1994)
Blood.
, vol.83
, pp. 1165-1173
-
-
Shipp, M.A.1
-
7
-
-
67749134847
-
Diffuse large B-cell lymphoma
-
Swerdlow SH Campo E Harris NL et al eds, Lyon, France: IARC Press
-
Stein H, Chan JKC, Warnke RA, et al. Diffuse large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press; 2008:233-237.
-
(2008)
World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissue
, pp. 233-237
-
-
Stein, H.1
Jkc, C.2
Warnke, R.A.3
-
8
-
-
0015150080
-
Report of the committee on hodgkin's disease staging classification
-
Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860-1861.
-
(1971)
Cancer Res.
, vol.31
, pp. 1860-1861
-
-
Carbone, P.P.1
Kaplan, H.S.2
Musshoff, K.3
-
9
-
-
9144237554
-
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
-
Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103:275-282.
-
(2004)
Blood.
, vol.103
, pp. 275-282
-
-
Hans, C.P.1
Weisenburger, D.D.2
Greiner, T.C.3
-
10
-
-
0036464704
-
De novo CD5+ diffuse large B-cell lymphoma: A clinicopathologic study of 109 patients
-
Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
-
(2002)
Blood.
, vol.99
, pp. 815-821
-
-
Yamaguchi, M.1
Seto, M.2
Okamoto, M.3
-
11
-
-
0023916786
-
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
-
Tracey KJ, Wei H, Manogue KR, et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med. 1988;167:1211-1227.
-
(1988)
J Exp Med.
, vol.167
, pp. 1211-1227
-
-
Tracey, K.J.1
Wei, H.2
Manogue, K.R.3
-
12
-
-
76949084622
-
TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion
-
Wu Y, Zhou BP. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102:639-644.
-
(2010)
Br J Cancer.
, vol.102
, pp. 639-644
-
-
Wu, Y.1
Zhou, B.P.2
-
13
-
-
2942675065
-
Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer
-
Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res. 2004;119:139-173.
-
(2004)
Cancer Treat Res.
, vol.119
, pp. 139-173
-
-
Shishodia, S.1
Aggarwal, B.B.2
-
14
-
-
0025737582
-
Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha
-
Ryffel B, Brockhaus M, Durmuller U, et al. Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha. Am J Pathol. 1991;139:7-15.
-
(1991)
Am J Pathol.
, vol.139
, pp. 7-15
-
-
Ryffel, B.1
Brockhaus, M.2
Durmuller, U.3
-
15
-
-
0023229234
-
Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes
-
Cuturi MC, Murphy M, Costa-Giomi MP, et al. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med. 1987;165: 1581-1594.
-
(1987)
J Exp Med.
, vol.165
, pp. 1581-1594
-
-
Cuturi, M.C.1
Murphy, M.2
Costa-Giomi, M.P.3
-
16
-
-
0024262991
-
Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells
-
Sung SS, Jung LK, Walters JA, et al. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J Exp Med. 1988;168:1539-1551.
-
(1988)
J Exp Med.
, vol.168
, pp. 1539-1551
-
-
Sung, S.S.1
Jung, L.K.2
Walters, J.A.3
-
17
-
-
0029887909
-
Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients
-
Salles G, Bienvenu J, Bastion Y, et al. Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol. 1996;93:352-359.
-
(1996)
Br J Haematol.
, vol.93
, pp. 352-359
-
-
Salles, G.1
Bienvenu, J.2
Bastion, Y.3
-
18
-
-
0023937119
-
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies
-
Cordingley FT, Bianchi A, Hoffbrand AV, et al. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet. 1988;1:969-971.
-
(1988)
Lancet.
, vol.1
, pp. 969-971
-
-
Cordingley, F.T.1
Bianchi, A.2
Hoffbrand, A.V.3
-
19
-
-
0031037239
-
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients
-
Warzocha K, Salles G, Bienvenu J, et al. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol. 1997;15:499-508.
-
(1997)
J Clin Oncol.
, vol.15
, pp. 499-508
-
-
Warzocha, K.1
Salles, G.2
Bienvenu, J.3
-
20
-
-
0028801694
-
TNF and Mae West or: Death from too much of a good thing
-
Tracey KJ. TNF and Mae West or: death from too much of a good thing. Lancet. 1995;345:75-76.
-
(1995)
Lancet.
, vol.345
, pp. 75-76
-
-
Tracey, K.J.1
-
21
-
-
0037644804
-
Biological functions of tumor necrosis factor cytokines and their receptors
-
Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003;14:185-191.
-
(2003)
Cytokine Growth Factor Rev.
, vol.14
, pp. 185-191
-
-
Pfeffer, K.1
-
22
-
-
0024593088
-
Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia
-
Digel W, Stefanic M, Schoniger W, et al. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood. 1989;73:1242-1246.
-
(1989)
Blood.
, vol.73
, pp. 1242-1246
-
-
Digel, W.1
Stefanic, M.2
Schoniger, W.3
-
23
-
-
0028338707
-
Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells
-
Boussiotis VA, Nadler LM, Strominger JL, et al. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci USA. 1994;91:7007-7011.
-
(1994)
Proc Natl Acad Sci USA.
, vol.91
, pp. 7007-7011
-
-
Boussiotis, V.A.1
Nadler, L.M.2
Strominger, J.L.3
-
24
-
-
0029670119
-
Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma
-
Macia J, Gomez X, Esquerda A, et al. Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma. Leuk Lymphoma. 1996;20:481-486.
-
(1996)
Leuk Lymphoma.
, vol.20
, pp. 481-486
-
-
Macia, J.1
Gomez, X.2
Esquerda, A.3
-
25
-
-
84862563412
-
Multiple cytokine-and chemokine-producing primary testicular diffuse large B-cell lym-phoma, not otherwise specified
-
Nakayama S, Yokote T, Iwaki K, et al. Multiple cytokine-and chemokine-producing primary testicular diffuse large B-cell lym-phoma, not otherwise specified. Leuk Res. 2012;36:e171-e174.
-
(2012)
Leuk Res.
, vol.36
-
-
Nakayama, S.1
Yokote, T.2
Iwaki, K.3
-
26
-
-
84858263994
-
Hypercalcaemia induced by tumour-derived parathyroid hormone-related protein and multiple cytokines in diffuse large B cell lymphoma, not otherwise specified
-
Nakayama-Ichiyama S, Yokote T, Iwaki K, et al. Hypercalcaemia induced by tumour-derived parathyroid hormone-related protein and multiple cytokines in diffuse large B cell lymphoma, not otherwise specified. Pathology. 2011;43:742-745.
-
(2011)
Pathology.
, vol.43
, pp. 742-745
-
-
Nakayama-Ichiyama, S.1
Yokote, T.2
Iwaki, K.3
-
27
-
-
32944461717
-
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
-
Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc. 2006;63:433-442.
-
(2006)
Gastrointest Endosc.
, vol.63
, pp. 433-442
-
-
Rutgeerts, P.1
Diamond, R.H.2
Bala, M.3
-
28
-
-
0035832515
-
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial
-
Chaudhari U, Romano P, Mulcahy LD, et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet. 2001;357:1842-1847.
-
(2001)
Lancet.
, vol.357
, pp. 1842-1847
-
-
Chaudhari, U.1
Romano, P.2
Mulcahy, L.D.3
-
29
-
-
79958108824
-
Advances in rheumatology: New targeted therapeutics
-
Tak PP, Kalden JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther. 2011;13:S5.
-
(2011)
Arthritis Res Ther.
, vol.13
-
-
Tak, P.P.1
Kalden, J.R.2
|